ClinConnect ClinConnect Logo
Search / Trial NCT06297148

The HIP Self-management Study

Launched by OSLO UNIVERSITY HOSPITAL · Feb 29, 2024

Trial Information

Current as of August 29, 2025

Recruiting

Keywords

Greater Trochanteric Pain Syndrome Lateral Hip Pain Gluteal Tendinopathy Trochanteric Bursitis Self Management

ClinConnect Summary

The HIP Self-management Study is a research trial that aims to find out if a self-management program can help people with greater trochanteric pain syndrome (GTPS) feel better compared to the usual care they currently receive. GTPS can cause pain on the outside of the hip and can affect daily activities. In this study, participants will be randomly placed into one of two groups: one will follow a self-management program, while the other will continue with standard care. The researchers want to see how well each method works in reducing pain and improving function over the next year.

To participate in this study, you need to be between 18 and 70 years old, have had hip pain on the outside for more than three months, and experience a certain level of pain. Some people may not qualify if they have severe osteoarthritis, a history of significant injury to the hip, or other specific health issues. Throughout the study, participants will be followed up at 3, 6, and 12 months to track their progress. If you're looking for new ways to manage your hip pain, this trial might be a good opportunity to consider.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants between 18 and 70 years of age
  • History of lateral hip pain \> 3 months
  • Reported average pain intensity the last week ≥ 3 on a numeric rating scale
  • Lateral hip pain is the main complaint
  • Pain on palpation of the greater trochanter region
  • * In addition, lateral hip pain on at least one of the following tests:
  • Single leg stance test: standing 30 seconds on the affected leg
  • FADER: passive stretch/compression of gluteus medius/minimus
  • FADER-R: static muscle test with resistance to internal hip rotation
  • ADD: passive stretch to hip adduction in sidelying
  • ADD-R: resisted hip abduction in sidelying
  • FABER (Patrick's) test
  • A positive test is defined as a spontaneous reproduction of the participant's lateral hip pain. In participants with bilateral lateral hip pain, the worst hip will be included, and the presence of bilateral pain will be documented.
  • Exclusion Criteria:
  • Significant back pain causing referred pain to the lateral hip
  • Clinical signs of radiculopathy
  • Symptomatic osteoarthritis
  • Other hip joint pathologies
  • History of trauma or surgery on the affected side
  • Pregnancy or post-partum pelvic pain (under 12 months since birth)
  • Active cancer
  • Not able to write, read, and comprehend Norwegian (without the use of an interpreter)

About Oslo University Hospital

Oslo University Hospital is a leading academic medical center in Norway, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes the development of new therapies and treatment strategies. With a multidisciplinary approach, Oslo University Hospital collaborates with various stakeholders, including researchers, healthcare professionals, and industry partners, to enhance clinical outcomes and contribute to the global medical community. Its dedication to ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and respect for participant welfare.

Locations

Oslo, , Norway

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported